It was only in January last year that I was attending a captive conference in Miami, meeting so many of the US captive community, learning from fascinating panels, networking over drinks, and somehow bumping into Superbowl players in the hotel.
At this point, working from home on a dreary London day as the country waits out another complete lockdown, those days in Miami feel less like a year ago and more like a decade. Oh to be attending non-virtual events again!
At 2021 begins, there seems to be hope in the air again. The development of multiple vaccines to fight the symptoms of Covid-19 and prevent illness means that before too long we may all be seeing each other in person and will never have to utter the words “Zoom Party” again.
The development of the vaccine has changed the game when it comes to managing the Covid-19 pandemic, and this month we have a cover feature on how a risk manager would go about covering the development of a vaccine through a captive. Director of group insurance at AstraZeneca Kevin Steed very candidly details how he tackled the issue on page 18, including explaining their business interruption policy, working with fronting partners, and employee benefits during Covid.
Elsewhere in the magazine, CEO of Generali Employee Benefits, Marco Sesana, gives his thoughts on how companies need to adapt to change during the pandemic or risk being left behind in a must-read comment piece on page 14.
On page 17 Captive Review talks to Tennessee captive insurance director Belinda Fortman in a quick-fire Q&A, and if you think you might have missed any captive news last year check out our summary of the biggest stories from 2020 on page 11.
If January 2021 is anything to go by, this year is going to be very big and very busy for the captive insurance industry. It’s an exciting opportunity for all of us, and Captive Review will be here to bring all the breaking news, in-depth interviews with experts, features analysing developments in the industry, and events (virtual and in-person) to bring you all together.